Cytotoxic activity of ursolic acid derivatives obtained by isolation and oxidative derivatization

Molecules

Volumn 18, Issue 8, 2013, Pages 8929-8944

  Mazumder, Kishor ^a,b   Tanaka, Katsunori ^c   Fukase, Koichi ^b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY CHITTAGONG   (Bangladesh)

^b OSAKA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

A431 human skin carcinoma cell line; Biomimetic oxidation; C6 rat glioma cell line; Cytochrome P450; Cytotoxicity; Dioxoruthenium(VI) tetraphenylporphyrin; Saurauja roxburghii; Ursolic acid

Indexed keywords

COROSOLIC ACID; PLANT EXTRACT; PORPHYRIN; TETRAPHENYLPORPHYRIN; TRITERPENE; URSOLIC ACID;

ANIMAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; HUMAN; OXIDATION REDUCTION REACTION; PATHOLOGY; PLANT LEAF; RAT; SKIN NEOPLASMS; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; DRUG EFFECT; REVIEW; SKIN TUMOR;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; OXIDATION-REDUCTION; PLANT EXTRACTS; PLANT LEAVES; PORPHYRINS; RATS; SKIN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 84883157800     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18088929     Document Type: Review

References (61)

1. Knowles, J.; Gromo, G. Target selection in drug discovery. Nat. Rev. Drug Discov. 2003, 2, 63-69.
2. Samuelsson, G. Drugs of Natural Origin: a Textbook of Pharmacognosy, 5th ed.; Swedish Pharmaceutical Press: Stockholm, Sweden, 2004; pp. 154-155.
3. Balick, M.J.; Cox, P.A. Plants, People, and Culture: the Science of Ethnobotany, 1st ed.; Freeman and Co: Scientific American Library, New York, NY, USA, 1997; pp. 8-9.
4. Kinghorn, A.D. Pharmacognosy in the 21st century. J. Pharm. Pharmacol. 2001, 53, 135-148.
5. Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.
6. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153.
7. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
8. van der Heijden, R.; Jacobs, D.I.; Snoeijer, W.; Hallard, D.; Verpoorte, R. The Catharanthus alkaloids: Pharmacognosy and biotechnology. Curr. Med. Chem. 2004, 11, 607-628.
9. Gordaliza, M.; Garcia, P.A.; Corral, J.M.; Castro, M.A.; Gomez-Zurita, M.A. Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon 2004, 44, 441-459.
10. Wall, M.E.; Wani, M.C. Camptothecin and taxol: From discovery to clinic. J. Ethnopharmacol. 1996, 51, 239-253.
11. Oberlies, N.H.; Kroll, D.J. Camptothecin and taxol: Historic achievements in natural products research. J. Nat. Prod. 2004, 67, 129-135.
12. Cragg, G.M.; D.J. Newman, D.J. A tale of two tumor targets: Topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. J. Nat. Prod. 2004, 67, 232-244.
13. Ikeda, Y.; Murakami, A.; H. Ohigashi, H. Ursolic acid: An anti- and pro-inflammatory triterpenoid. Mol. Nutr. Food Res. 2008, 52, 26-42.
14. Pisha, E.; Chai, H.; Lee, I.S.; Chagwedera, T.E.; Farnsworth, N.R.; Cordell, G.A.; Beecher, C.W.; Fong, H.H.; Kinghorn, A.D.; Brown, D.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1995, 1, 1046-1051.
15. Andersson, D.; Cheng, Y.; Duan, R.D. Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J. Cancer Res. Clin. Oncol. 2008, 134, 101-107.
16. Bonaccorsi, I.; Altieri, F.; Sciamanna, I.; Oricchio, E.; Grillo, C.; Contartese, G.; Galati, E.M. Endogenous reverse transcriptase as a mediator of ursolic acid's antiproliferative and differentiating effects in human cancer cell lines. Cancer Lett. 2008, 263, 130-139.
17. Ma, C.-M.; Cai, S.-Q.; Cui, J.-R.; Wang, R.-Q.; Tu, P.-F.; Hattori, M.; Daneshtalab, M. The cytotoxic activity of ursolic acid derivatives. Eur. J. Med. Chem. 2005, 40, 582-589.
18. Shao, J.-W.; Dai, Y.-C.; Xue, J.-P.; Wang, Ji.-C.; Lin, F.-P.; Guo, Y.-H. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives. Eur. J. Med. Chem. 2011, 46, 2652-2661.
19. Chadalapaka, G.; Jutooru, I.; McAlees, A.; Stefanac, T.; Safe, S. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg. Med. Chem. Lett. 2008, 18, 2633-2639.
20. Park, B.C.; Paek, S.H.; Lee, Y.S.; Kim, S.J.; Lee, E.S.; Choi, H.G.; Yong, C.S.; Kim, J.A. Inhibitory effects of asiatic acid on 7, 12-dimethylbenz[<]anthracene and 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice. Biol. Pharm. Bull. 2007, 30, 176-179.
21. Chen, I.H.; Chang, F.R.; Wu, C.C.; Chen, S.L.; Hsieh, P.W.; Yen, H.F.; Du, Y.C.; Wu, Y.C. Cytotoxic triterpenoids from the leaves of Microtropis fokienensis. J. Nat. Prod. 2006, 69, 1543-1546.
22. Mazumder, K.; Swiu, E.R.O.; Nozaki, S.; Watanabe, Y.; Tanaka, K.; Fukase, K. Ursolic Acid Derivatives from Bangladeshi medicinal plant, Sarauja roxburghii: Isolation and cytotoxic activity against A431 and C6 glioma cell lines. Phytochem. Lett. 2011, 4, 287-291.
23. Tanaka, K.; Mazumder, K.; Siwu, E.R.O.; Nozaki, S.; Watanabe, Y.; Fukase, K. Auxiliarydirected oxidation of ursolic acid by "Ru"-porphyrins: Chemical modulation of cytotoxicity against tumor cell lines. Tetrahedron Lett. 2012, 53, 1756-1759.
24. Hsu, Y.-L.; Kuo, P.L.; Lin, L.T.; Lin, C.C. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J. Phamacol. Exp. Ther. 2004, 313, 333-344.
25. Seo, S.; Tomita, Y.; Tori, K. Carbon-13 NMR spectra of urs-12enes and application of structural assignments of components of Isodon japonicus tissue cultures. Tetrahedron Lett. 1975, 16, 7-10.
26. Reher, G.; Budensisky, M. Triterpenoids from plants of Sanguisorbae. Photochemistry 1992, 31, 3909-3914.
27. Inada, A.; Kobayashi, M.; Murata, H.; Nakanishi, T. Two new triterpenoid glycosides from leaves of Ilex chinensis SIMS. Chem. Pharm. Bull. 1987, 35, 841-842.
28. Kojima, H.; Ogura, H. Configurational studies on hydroxyl groups at C-2, 3 and C-23 of oleanene and ursene-type trirerpenes by NMR spectroscopy. Phytochemistry 1989, 28, 1703-1989.
29. Bilia, A.R.; Mendezb, J.; Morellia, I. Phytochemical investigations of Licania genus. Flavonoids and triterpenoids from Licania carii. Pharm. Acta Helv. 1996, 71, 191-197.
30. Lee, C.K. Ursane triterpenoids from leaves of Melaleuca leucadendron. Phytochemistry 1998, 49, 1119-1122.
31. Reyes-Zurita, F.J.; Rufino-Palomares, E.E.; Lupiáñez, J.A.; Cascante, M. Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett. 2009, 273, 44-54.
32. Murahashi, S.-I.; Zhang, D. Ruthenium catalyzed biomimetic oxidation in organic synthesis inspired by cytochrome P-450. Chem. Soc. Rev. 2008, 37, 1490-1501.
33. P450-Mediated oxidation of ursolic acid derivatives, see: Sivakumar, G.; Vail, D.R.; Nair, V.; Bolivar, F.M.; Lay, J.O. Corosolic acid the future anti-diabetic drug? Biotechnol. J. 2009, 4, 1704-1711.
34. Patocka, J.J. Biologically active pentacyclic triterpenes and their current medicine signification. Appl. Biomed. 2003, 1, 7-12.
35. Ma, C.M.; Nakamura, N.; Hattori, M.; Kakuda, H.; Qiao, J.C.; Yu, H.L.J. Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia. Nat. Prod. 2000, 63, 238-242.
36. Saraswat, B.; Visen, P.K.; Agarwal, D.P. Ursolic acid isolated from Eucalyptus tereticornis protects against ethanol toxicity in isolated rat hepatocytes. Phytother. Res. 2000, 14, 163-166.
37. Chattopadhyay, D.; Arenachalam, G.; Mandal, A. B.; Sur, T. K.; Mandal, S. C.; Bhattacharya, S. K. Antimicrobial and anti-inflammatory activity of folklore: Mallotus peltatus leaf extract. J. Ethnopharmacol. 2002, 82, 229-237.
38. Li, J.; Guo, W.J.; Yang, Q.Y. Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. World J. Gastroenterol. 2002, 8, 493-495.
39. Anderson, D.; Liu, J.J.; Nilsson, A. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res. 2003, 23, 3317-3322.
40. Choi, Y.H.; Baek, J.H.; Yoo, M.A.; Chung, H.Y.; Kim, N.D.; Kim, K.W. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. J. Oncol. 2000, 17, 565-570.
41. Laszczyk, M.N. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med. 2009, 15, 1549-1560.
42. Breslow, R.; Baldwin, S.; Flechtner, T.; Kalicky, P.; Liu, S.; Washburn, W. Remote oxidation of steroids by photolysis of attached benzophenone groups. J. Am. Chem. Soc. 1973, 95, 3251-3262.
43. Das, S.; Incarvito, C.D.; Crabtree, R.H.; Brudvig, G.W. Molecular recognition in the selective oxygenation of saturated C-H bonds by a dimanganese catalyst. Science 2006, 312, 1941-1943.
44. Chen, M.S.; White, C.M. A Predictably Selective Aliphatic C-H Oxidation Reaction for Complex Molecule Synthesis. Science 2007, 318, 783-787.
45. Murahashi, S.-I. Development of biomimetic catalytic oxidation methods and non-salt methods using transition metal-based acid and base amphiphilic catalysts. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2011, 87, 242-253.
46. Representative example, see: Chen, K.; Baran, P.S. Total synthesis of eudesmane terpenes by site-selective C-H oxidations. Nature 2009, 459, 824-828.
47. Zhang, K; Damaty, E.l.S.; Fasan, R. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity. J. Am. Chem. Soc. 2011, 133, 3242-3245.
48. Costas, M. Selective C-H oxidation catalyzed by metalloporphyrins. Coord. Chem. Rev. 2011, 255, 2912-2932.
49. Ogawa, S.; Wakatsuki, Y.; Makino, M.; Fujimoto, Y.; Yasukawa, K.; Kikuchi, T.; Ukiya, M.; Akihisa, T.; Iida, T. Oxyfunctionalization of unactivated C-H bonds in triterpenoids with tert-butylhydroperoxide catalyzed by meso-5,10,15,20-tetramesitylporphyrinate osmium(II) carbonyl complex. Chem. Phys. Lipids 2010, 163, 165-171.
50. Konoike, T.; Araki, Y.; Kanda, Y. A novel allylic hydroxylation of sterically hindered olefins by Fe-porphyrin-catalyzed mCPBA oxidation. Tetrahedron Lett. 1999, 40, 6971-6974.
51. Shingaki, T.; Miura, K.; Higuchi, T.; Hirobe, M.; Nagano, T. Regio- and stereo-selective oxidation of steroids using 2,6-dichloropyridine N-oxide catalysed by rutheniumporphyrins. Chem. Commun. 1997, 861-862.
52. Che, C.-M.; Huang, J.-S. Metalloporphyrin-based oxidation systems: From biomimetic reactions to application in organic synthesis. Chem. Commun. 2009, 27, 3996-4015.
53. Rillema, D.P.; Nagle, J.K.; Barringer, L.F.; Meyer, T.J. Redox properties of metalloporphyrin excited states, lifetimes, and related properties of a series of para-substituted tetraphenylporphyrin carbonyl complexes of ruthenium(II). J. Am. Chem. Soc. 1981, 103, 56-62.
54. Tkachev, A.V.; Denisov, A.Y.; Gatilov, Y.V.; Bagryanskaya, I.Y.; Shevtsov, S.A.; Rybalova, T.V. Acetic acid oxidation of ursolic acid and related compounds. Tetrahedron 1994, 50, 11459-11488.
55. Pereira, S.I.; Freire, C.S.R.; Neto, C.P.; Silvestre, A.J.D.; Silva, A.M.S. Chemical composition of the epicuticular wax from the fruits of Eucalyptus globulus. Phytochem. Anal. 2005, 16, 364-369.
56. Syamasundar, K.V.; Mallavarapu, G.R.; Krishna, M. Triterpenoids of the resin of Bursera delpechiana. Phytochemistry 1991, 30, 362-363.
57. Luis, J.G.; Andres, L.S. New ursane type triterpenes from Salvia mellifera greene. Nat. Prod. Lett. 1999, 13, 187-194.
58. Li, Y.; Matsuda, H.; Yoshikawa, M. Effects of oleanolic acid glycosides on gastrointestinal transit and ileus in mice. Bioorg. Med. Chem. 1999, 7, 1201-1205.
59. Wen, X.; Xia, J.; Cheng, K.; Zhang, L.; Zhang, P.; Liu, J.; Zhang, L.; Ni, P.; Sun, H. Pentacyclic triterpenes. Part 5: Synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases. Bioorg. Med. Chem. Lett. 2007, 17, 5777-5782.
60. 2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett. 2002, 186, 83-91.
61. Cho, C.W.; Choi, D.S.; Cardone, M.H.; Kim, C.W.; Sinskey, A.J.; Rha, C. Glioblastoma cell death induced by asiatic acid. Cell Biol. Toxicol. 2006, 22, 393-408.